Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2025Frontiers in ImmunologyOpen Access

Melatonin as an anti-inflammatory hormone bridging migraine relief and cancer immunity enhancement: a literature review

View Full Paper
Ask AI
Bookmark
Share

Authors

QZQian ZhuYJYang JinJZJieying Zhang

Discussion

Loading...

Member takes

Overview

Literature review highlights melatonin's role in migraine relief and cancer immunity enhancement, suggesting novel treatment pathways.

Key Points

  • Main finding shows melatonin's dual function in alleviating migraine symptoms and boosting cancer immunity.
  • Key evidence indicates melatonin supplementation significantly reduces migraine frequency while enhancing immune response.
  • Approach combines a review of molecular pharmacology and current pre-clinical trials addressing melatonin's effects.
  • Significance lies in identifying therapeutic strategies that bridge migraine management and cancer treatment, enhancing patient care.

Cite This Study

Zhu et al. (2025) studied this question.

synapsesocial.com/papers/689a0939e6551bb0af8ce90fhttps://doi.org/10.3389/fimmu.2025.1644066
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Melatonin at the Crossroads of Oxidative Stress, Immunity, and Cancer Therapy2026
  2. 2Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications2025
  3. 3Melatonin and Virus induced Oncogenic Factors2025
  4. 4Melatonin: a natural guardian in cancer treatment2025
  5. 5Melatonin as the Missing Link Between Sleep Deprivation and Immune Dysregulation: A Narrative Review2025